YKLTY(YKLTY)
YKLTY
8/30/26
Yakult Honsha Co.,Ltd. (YKLTY)
Sunday
4:53 AM
ThesisYakult Honsha Co.,Ltd.: the story is balanced — International volume growth, particularly in China, Indonesia, India…
Revenue Outlook
What Moves the Stock
- 01International volume growth, particularly in China, Indonesia, India, and Southeast Asian markets where penetration remains low
- 02Japanese yen exchange rate movements - weaker yen boosts translated earnings from overseas operations (60%+ of revenue)
- 03Raw material cost inflation for milk, sugar, and packaging materials which directly impact gross margins
- 04Competitive dynamics in probiotic/functional beverage category, including new entrants and yogurt drink alternatives
- 05Regulatory approvals and market entry progress in new geographies
- 06Probiotic beverages (Yakult core products) - estimated 75-80% of revenue, sold primarily in single-serve bottles
- 07Pharmaceuticals and cosmetics - estimated 15-20% of revenue, including cancer immunotherapy drugs and skincare products
- 08Other food and beverage products - estimated 5% of revenue, including juice drinks and supplements
FY2026 Snapshot
- Revenue
- $515.8B
- Rev. Growth
- +3.2%
- Gross Margin
- 58.8%
- Op. Margin
- 9.2%
- Net Margin
- 9.1%
- Net Income
- $46.9B
- NI Growth
- +3.0%
- EPS
- $79.89
YKLTY Chart
My Notes
- value/dividend - The stock attracts defensive investors seeking stable cash flows, consistent dividends…
- Low direct sensitivity given minimal debt (0.17 D/E ratio) and strong cash generation.
- Watch on earnings: USD/JPY and CNY/JPY exchange rates - direct impact on translated international earnings, China retail sales growth and consumer confidence - leading indicator for largest international market, Global milk and sugar commodity prices - key COGS inputs affecting gross margins.
One Sentence Summary:
Yakult Honsha Co.,Ltd.: the story is balanced — international volume growth, particularly in china, indonesia, india, and southeast asian markets where penetration remains low.
Auto-composed from Stock Alarm intelligence, financial statements, and analyst estimates. Not investment advice.